AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29210932 — intervention group
Group type: COMPARATOR
Intervention: Short Physical Performance Battery (SPPB)
Number of subjects: 141
Study 29351710 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based self-help program Deprexis
Number of subjects: 0
Study 29351710 — intervention group
Group type: COMPARATOR
Intervention: Control group (no access to Deprexis)
Number of subjects: 0
Study 27454856 — intervention group
Group type: EXPERIMENTAL
Intervention: LCHF (approximately 70% fats)
Number of subjects: 7
Study 27454856 — intervention group
Group type: COMPARATOR
Intervention: ICIF (approximately 50% fats)
Number of subjects: 7
Study 27454856 — intervention group
Group type: COMPARATOR
Intervention: C (approximately 25% fats)
Number of subjects: 7
Study 25946916 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered acupressure intervention (5 sessions, 3 times a day for 2 weeks)
Number of subjects: 54
Study 25946916 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual activities)
Number of subjects: 54
Study 22950651 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural cycle FET (NC-FET)
Number of subjects: 1150
Study 22950651 — intervention group
Group type: COMPARATOR
Intervention: Artificial cycle FET (AC-FET)
Number of subjects: 1150
Study 19891806 — intervention group
Group type: EXPERIMENTAL
Intervention: Active medication
Number of subjects: 120
Study 19891806 — intervention group
Group type: COMPARATOR
Intervention: Pill-placebo
Number of subjects: 120
Study 18798940 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided nursing (CAN) diagnosis system
Number of subjects: 42
Study 18798940 — intervention group
Group type: COMPARATOR
Intervention: Handbook of nursing diagnosis
Number of subjects: 42
Study 15673353 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity counseling intervention
Number of subjects: 336
Study 15673353 — intervention group
Group type: COMPARATOR
Intervention: Control condition (counseling about tobacco cessation)
Number of subjects: 336
Study 11831541 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (100 mg daily for 4 days)
Number of subjects: 12
Study 11831541 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal bromazepam (3 mg)
Number of subjects: 12
Study 11831541 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control for fluconazole)
Number of subjects: 12
Study 10348276 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioactive iodine (131I) ablation doses ranging from less than 30 mCi to 100 mCi.
Number of subjects: 0
Study 8665549 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (mean dose, 58 mg)
Number of subjects: 8
Study 8665549 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil (mean dose, 11 mg)
Number of subjects: 8
Study 8665549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 2341121 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (1 mg intravenously)
Number of subjects: 32
Study 2341121 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetropium bromide (5 mg intravenously)
Number of subjects: 32
Study 2341121 — intervention group
Group type: COMPARATOR
Intervention: Placebo (physiological saline)
Number of subjects: 32
Study 10248157 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive health behavior program for obese children
Number of subjects: 1252
Study 10248157 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking prevention program
Number of subjects: 1252
Study 10248157 — intervention group
Group type: COMPARATOR
Intervention: General health education program
Number of subjects: 1252
Study 31571633 — intervention group
Group type: EXPERIMENTAL
Intervention: RISUG (120 μl as bilateral vas intraluminal injection)
Number of subjects: 139
Study 28327167 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-hour clamp (Group A)
Number of subjects: 120
Study 28327167 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-hour clamp (Group B)
Number of subjects: 120
Study 28327167 — intervention group
Group type: COMPARATOR
Intervention: Conventional negative drainage (Group C)
Number of subjects: 120
Study 26573144 — intervention group
Group type: EXPERIMENTAL
Intervention: kContact intervention
Number of subjects: 0
Study 23025248 — intervention group
Group type: EXPERIMENTAL
Intervention: Living in the Face of Trauma (LIFT) intervention
Number of subjects: 247
Study 21980445 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi-CRM₁₉₇ vaccine (25.0 µg of Vi antigen)
Number of subjects: 0
Study 21980445 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi-CRM₁₉₇ vaccine (1.25 µg, 5.0 µg, and 12.5 µg of Vi antigen)
Number of subjects: 0
Study 21980445 — intervention group
Group type: COMPARATOR
Intervention: Licensed polysaccharide vaccine (25.0 µg of Vi antigen)
Number of subjects: 0
Study 18277222 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy skills training group (16 sessions, once-weekly)
Number of subjects: 24
Study 18277222 — intervention group
Group type: COMPARATOR
Intervention: Wait-list condition
Number of subjects: 24
Study 17135639 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel plus cyclophosphamide (TC) (75 and 600 mg/m2, respectively; n = 506)
Number of subjects: 1016
Study 17135639 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin plus cyclophosphamide (AC) (60 and 600 mg/m2, respectively; n = 510)
Number of subjects: 1016
Study 17135639 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel plus cyclophosphamide (TC)
Number of subjects: 1016
Study 17135639 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin plus cyclophosphamide (AC)
Number of subjects: 1016
Study 14511925 — intervention group
Group type: EXPERIMENTAL
Intervention: Six fractions per week
Number of subjects: 1476
Study 14511925 — intervention group
Group type: COMPARATOR
Intervention: Five fractions per week
Number of subjects: 1476
Study 11104591 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched diet (enteral diet supplemented with arginine)
Number of subjects: 44
Study 11104591 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric, isonitrogenous control diet
Number of subjects: 44
Study 9311401 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium laevulinate (initial bolus 8 mmol: then 8 mmol/h)
Number of subjects: 24
Study 9311401 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 9311401 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium laevulinate
Number of subjects: 24
Study 8513849 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril 2.5 mg
Number of subjects: 87
Study 8513849 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril 2.5 mg plus Hydrochlorothiazide 12.5 mg
Number of subjects: 87
Study 3644367 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice condition (selected from three equally effective preparations)
Number of subjects: 0
Study 3644367 — intervention group
Group type: COMPARATOR
Intervention: Instruction only
Number of subjects: 0
Study 3644367 — intervention group
Group type: COMPARATOR
Intervention: Information condition (same sensation information as choice)
Number of subjects: 0
Study 3644367 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice condition (for high DFC patients)
Number of subjects: 0
Study 29775076 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking with breathing intervention for 12 weeks
Number of subjects: 90
Study 28815307 — intervention group
Group type: EXPERIMENTAL
Intervention: Local Anesthesia with Monitored Anesthesia Care (LA-MAC)
Number of subjects: 60
Study 28815307 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 60
Study 23742125 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyurethane film surgical dressing (Opsite Post‐Op Visible)
Number of subjects: 0
Study 23742125 — intervention group
Group type: COMPARATOR
Intervention: Gauze and tape surgical dressings
Number of subjects: 0
Study 24004888 — intervention group
Group type: EXPERIMENTAL
Intervention: 766 mg total blueberry polyphenols
Number of subjects: 21
Study 24004888 — intervention group
Group type: EXPERIMENTAL
Intervention: 1278 mg total blueberry polyphenols
Number of subjects: 21
Study 24004888 — intervention group
Group type: EXPERIMENTAL
Intervention: 1791 mg total blueberry polyphenols
Number of subjects: 21
Study 24004888 — intervention group
Group type: COMPARATOR
Intervention: Control drink (0 mg total blueberry polyphenols)
Number of subjects: 21
Study 24004888 — intervention group
Group type: EXPERIMENTAL
Intervention: 319 mg total blueberry polyphenols
Number of subjects: 21
Study 24004888 — intervention group
Group type: EXPERIMENTAL
Intervention: 637 mg total blueberry polyphenols
Number of subjects: 21
Study 21961484 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide 10 μg
Number of subjects: 62
Study 21961484 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 21961484 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg orally (positive control)
Number of subjects: 62
Study 21961484 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma glucose
Number of subjects: 62
Study 21961484 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma insulin
Number of subjects: 62
Study 18182963 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 122
Study 18182963 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 122
Study 18182963 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine + Methylphenidate
Number of subjects: 122
Study 18182963 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 16540710 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic group (inspired O2 fraction = 14.5%, n = 9)
Number of subjects: 15
Study 16540710 — intervention group
Group type: COMPARATOR
Intervention: Normoxic group (inspired O2 fraction = 20.9%, n = 6)
Number of subjects: 15
Study 12699262 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose monophasic oral contraceptive continuously
Number of subjects: 0
Study 12699262 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestins (oral, intramuscular, or IUD)
Number of subjects: 0
Study 12699262 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist with immediate add-back therapy
Number of subjects: 0
Study 12699262 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat surgery
Number of subjects: 0
Study 12699262 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy postoperatively
Number of subjects: 0
Study 10823097 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure at the P6 point
Number of subjects: 94
Study 10823097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 8613630 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide nasal spray (110 micro g in each nostril once daily)
Number of subjects: 239
Study 8613630 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide nasal spray
Number of subjects: 239
Study 8613630 — intervention group
Group type: COMPARATOR
Intervention: Astemizole (10 mg once daily)
Number of subjects: 239
Study 1358234 — intervention group
Group type: EXPERIMENTAL
Intervention: Balsalazide 4 g/day
Number of subjects: 133
Study 1358234 — intervention group
Group type: COMPARATOR
Intervention: Balsalazide 2 g/day
Number of subjects: 133
Study 3965343 — intervention group
Group type: EXPERIMENTAL
Intervention: Golytely lavage (3‐4 L)
Number of subjects: 18
Study 3965343 — intervention group
Group type: COMPARATOR
Intervention: Standard preparation (48‐h clear liquid diet, 240 ml of magnesium citrate and 'X‐Prep' senna derivative)
Number of subjects: 18
Study 31375142 — intervention group
Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (Early-PN)
Number of subjects: 4640
Study 31375142 — intervention group
Group type: COMPARATOR
Intervention: Late parenteral nutrition (Late-PN)
Number of subjects: 4640
Study 31375142 — intervention group
Group type: EXPERIMENTAL
Intervention: Infection or IFI
Number of subjects: 4640
Study 31375142 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 4640
Study 29805085 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) using JCP droplets or HDM tablets
Number of subjects: 0
Study 29805085 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26117308 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy drinkers (HD)
Number of subjects: 156
Study 26117308 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy drinkers (HD) with high AUD symptoms
Number of subjects: 156
Study 26117308 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy drinkers (HD) with low AUD symptoms
Number of subjects: 156
Study 26117308 — intervention group
Group type: COMPARATOR
Intervention: Light drinkers (control)
Number of subjects: 156
Study 24185212 — intervention group
Group type: EXPERIMENTAL
Intervention: acu-TENS on right LI4 and LI11 points
Number of subjects: 36
Study 24185212 — intervention group
Group type: COMPARATOR
Intervention: acu-TENS to bilateral kneecaps
Number of subjects: 36
Study 24185212 — intervention group
Group type: COMPARATOR
Intervention: sham acu-TENS on right LI4 and LI11 points
Number of subjects: 36
Study 24185212 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall C‐MMASS indices for experimental, control, and placebo groups
Number of subjects: 36
Study 22085595 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (Med Diet) enriched in MUFA with virgin olive oil
Number of subjects: 20
Study 20463579 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate
Number of subjects: 134
Study 20463579 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release oral morphine sulfate
Number of subjects: 134
Study 20463579 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Relief Verbal Response Scale
Number of subjects: 134
Study 20463579 — intervention group
Group type: EXPERIMENTAL
Intervention: Global Medication Performance Scale
Number of subjects: 134
Study 18595975 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral corticosteroid bursts (0, 1 to 4, and >=5 courses)
Number of subjects: 877
Study 18595975 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative inhaled corticosteroid use
Number of subjects: 877
Study 16091765 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapeseed oil diet
Number of subjects: 9
Study 16091765 — intervention group
Group type: COMPARATOR
Intervention: Olive oil diet
Number of subjects: 9
Study 11892372 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of foot ulcers in patients with diabetes
Number of subjects: 100000
Study 10510577 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (i.m.) injection with concentrated PHKCV
Number of subjects: 0
Study 10510577 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (i.m.) injection with concentrated PHKCV after boosting
Number of subjects: 0
Study 10510577 — intervention group
Group type: COMPARATOR
Intervention: Five routine doses of rabies vaccine
Number of subjects: 0
Study 10510577 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (i.m.) two or three doses after i.d. 0.1 mL nonconcentrated PHKCV
Number of subjects: 0
Study 8610079 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐hr training program on physicians' lipid intervention knowledge, attitudes, and skills
Number of subjects: 0
Study 1436604 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg of UDCA‐hemisuccinate orally twice a day for six months
Number of subjects: 36
Study 1436604 — intervention group
Group type: COMPARATOR
Intervention: 200 mg of S‐adenosyl‐methionine (SAMe) twice a day for six months
Number of subjects: 36
Study 3548109 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional pancreatic enzyme preparation (Pankreon 700; 3 X 3 dragees daily) with cimetidine (300 mg)
Number of subjects: 8
Study 3548109 — intervention group
Group type: EXPERIMENTAL
Intervention: New pH-sensitive enzyme preparation (Kreon; 3 X 6 capsules daily) comprising acid-protected granules
Number of subjects: 8
Study 3548109 — intervention group
Group type: COMPARATOR
Intervention: Conventional pancreatic enzyme preparation (Pankreon 700; 3 X 3 dragees daily) without cimetidine
Number of subjects: 8
Study 31384878 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Dose (LD) group - 2.5 × 10^9 CFU
Number of subjects: 90
Study 31384878 — intervention group
Group type: EXPERIMENTAL
Intervention: High Dose (HD) group - 1 × 10^10 CFU
Number of subjects: 90
Study 31384878 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 90
Study 29132175 — intervention group
Group type: EXPERIMENTAL
Intervention: 2L PEG plus simethicone
Number of subjects: 579
Study 29132175 — intervention group
Group type: COMPARATOR
Intervention: 2L PEG
Number of subjects: 579
Study 27272714 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-gauge vitrectomy
Number of subjects: 50
Study 27272714 — intervention group
Group type: COMPARATOR
Intervention: 25-gauge vitrectomy
Number of subjects: 50
Study 23740093 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysfunction markers (comorbidity, medication consumption, doctor's visits, difficulties in activities of daily living)
Number of subjects: 1369
Study 23740093 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysfunction markers
Number of subjects: 1369
Study 23330127 — intervention group
Group type: EXPERIMENTAL
Intervention: Carnosine added to treatment protocol for chronic brain ischemia
Number of subjects: 0
Study 23330127 — intervention group
Group type: COMPARATOR
Intervention: Control group (no carnosine)
Number of subjects: 0
Study 20426644 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid angioplasty with stent placement (CAS)
Number of subjects: 0
Study 20426644 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 0
Study 18703676 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency pulsed currents (LPC) with a 50-Hz pulse frequency
Number of subjects: 26
Study 18703676 — intervention group
Group type: EXPERIMENTAL
Intervention: Russian current (RC) burst modulated at 50 Hz with 25 cycles per burst
Number of subjects: 26
Study 18703676 — intervention group
Group type: EXPERIMENTAL
Intervention: KACs modulated at 20 Hz
Number of subjects: 26
Study 18703676 — intervention group
Group type: EXPERIMENTAL
Intervention: KACs modulated at 50 Hz with 10 cycles per burst
Number of subjects: 26
Study 18703676 — intervention group
Group type: EXPERIMENTAL
Intervention: KACs modulated at 20 Hz with 10 cycles per burst
Number of subjects: 26
Study 15905297 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted hatching (laser system)
Number of subjects: 60
Study 15905297 — intervention group
Group type: COMPARATOR
Intervention: Zona intact (control)
Number of subjects: 60
Study 12618251 — intervention group
Group type: EXPERIMENTAL
Intervention: Desogestrel (DSG)
Number of subjects: 707
Study 12618251 — intervention group
Group type: EXPERIMENTAL
Intervention: Norgestimate (NGM)
Number of subjects: 707
Study 12618251 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestodene (GSD)
Number of subjects: 707
Study 12618251 — intervention group
Group type: COMPARATOR
Intervention: Levonorgestrel (LNG)
Number of subjects: 707
Study 12618251 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinylestradiol (50 microg)
Number of subjects: 707
Study 12618251 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinylestradiol (30 microg)
Number of subjects: 707
Study 9469691 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin-sulbactam
Number of subjects: 197
Study 9469691 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 197
Study 7999656 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine and morphine
Number of subjects: 32
Study 7999656 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular morphine
Number of subjects: 32
Study 7999656 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 32
Study 2967781 — intervention group
Group type: EXPERIMENTAL
Intervention: Tizanidine (4 mg three times daily) plus ibuprofen (400 mg three times daily)
Number of subjects: 105
Study 2967781 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus ibuprofen (400 mg three times daily)
Number of subjects: 105
Study 31866441 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 0
Study 29884608 — intervention group
Group type: EXPERIMENTAL
Intervention: HeLP-Diabetes (interactive, theoretically-informed Web-based self-management program)
Number of subjects: 374
Study 29884608 — intervention group
Group type: COMPARATOR
Intervention: Usual care plus access to a comparator website (basic information only)
Number of subjects: 374
Study 28177710 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g of bioactive collagen peptides (BCP) per day for 12 weeks
Number of subjects: 139
Study 28177710 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study 26116829 — intervention group
Group type: EXPERIMENTAL
Intervention: Homemade chicken liver baby food (CLBF)
Number of subjects: 50
Study 26116829 — intervention group
Group type: COMPARATOR
Intervention: Ground beef baby food (GBBF)
Number of subjects: 50
Study 26116829 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers' preferences for liver and beef
Number of subjects: 50
Study 23538593 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 34
Study 23538593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 21906250 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable hemodynamic monitoring (IHM) system used in treatment group
Number of subjects: 400
Study 21906250 — intervention group
Group type: COMPARATOR
Intervention: Control group without access to hemodynamic information
Number of subjects: 400
Study 18316672 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 66
Study 18316672 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 16928485 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 222
Study 16928485 — intervention group
Group type: COMPARATOR
Intervention: PCI
Number of subjects: 222
Study 14512859 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational interventions
Number of subjects: 78
Study 14512859 — intervention group
Group type: COMPARATOR
Intervention: Practice nurses
Number of subjects: 78
Study 11153617 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 150 mg/kg iv bolus over 15 mins and continuous infusion of 12.5 mg/kg/hr over 90 mins (n = 30)
Number of subjects: 60